To better understand the molecular pathways by which MDSC, which expanded in MS patients, exerts their suppressive function, we examined several factors including Arg‐1 that is known to mediate the immunosuppressive activity of MDSC.7 This evidence concerns the gene ARG1 and myeloid sarcoma.